The global parasitic diseases therapeutic market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). These drugs are generally effective and work well against a limited number of certain parasites within a very specific class of the parasites. The major factors that are driving the growth of the global parasitic drugs market include the growing prevalence of parasitic infections among the global populace, economic nature of the drugs, rising novel drug treatment, ease of direct purchase due to the access to OTC drugs, high acceptance and adoption in emerging economies, and the constant innovations and developments of drugs.
Get Free Sample link @ https://www.omrglobal.com/request-sample/parasitic-diseases-therapeutic-market
Further, the market growth is also driven by the growing number of programs initiatives to create awareness among the population regarding such infections. Thus, to further eliminate parasitic diseases, such programs and campaigns are further anticipated to contribute to market growth. Further, increased funding for R&D coupled with the high prevalence of parasitic infections, and the approval of therapeutics to treat parasitic diseases are the major factors adding to the overall market growth. Researchers around the globe are increasingly focusing on the development of vaccines due to the high prevalence of malaria.
Diseases such as visceral leishmaniasis and cutaneous leishmaniasis can be prevented with the help of prophylactic vaccines. The development and consumption of such vaccines help in controlling parasitic diseases. This development is expected to have a positive impact on the overall market growth. The major drugs that are covered in the market include antiprotozoal therapeutics, anthelminthic therapeutics, and Scabicides and pediculicides therapeutics. Furthermore, some key players operating in the market include Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, and Pfizer Inc., among others.
Full report of Parasitic Diseases Therapeutic Market available @ https://www.omrglobal.com/industry-reports/parasitic-diseases-therapeutic-market
Market Coverage
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, and Pfizer Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Parasitic Diseases Therapeutic Market by Segment
By Product
- Antiprotozoal Therapeutics
- Anthelminthic Therapeutics
- Scabicides
- Pediculicides Therapeutics
By Application
- Hospital
- Clinic
- Homecare Setting
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/parasitic-diseases-therapeutic-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
